Gankyrin oncoprotein overexpression as a critical factor for tumor growth in human esophageal squamous cell carcinoma and its clinical significance-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Gankyrin oncoprotein overexpression as a critical factor for tumor growth in human esophageal squamous cell carcinoma and its clinical significance

Published:2007-10-12 Issue:2 Volume:122 Page:325-332
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Ortiz Cristian M.,Ito Tetsuo,Tanaka Eiji,Tsunoda Shigeru,Nagayama Satoshi,Sakai Yoshiharu,Higashitsuji Hiroaki,Fujita Jun,Shimada Yutaka

Funder

Japanese Ministry of Education, Culture, Sports, Science and Technology

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference43 articles.

1. Estimates of the worldwide mortality from 25 cancers in 1990;Pisani;Int J Cancer,1999

2. Adjuvant and neoadjuvant therapy for esophageal cancer: a critical reappraisal;Visser;Surg Oncol,2003

3. Prediction of lymph node metastasis with use of artificial neural network based on gene expression profiles in esophageal squamous cell carcinoma;Kan;Ann Surg Oncol,2004

4. Analysis of gene amplification and overexpression in human esophageal-carcinoma cell lines;Kanda;Int J Cancer,1994

5. Multiple types of aberrations in the p16 (INK4a) and the p15(INK4b) genes in 30 esophageal squamous-cell-carcinoma cell lines;Tanaka;Int J Cancer,1997

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gankyrin inhibits ferroptosis through the p53/SLC7A11/GPX4 axis in triple-negative breast cancer cells;Scientific Reports;2023-12-08

2. Gankyrin inhibits ferroptosis through the P53/SLC7A11/GPX4 axis in Triple-negative breast cancer cells;2023-10-05

3. Gankyrin: At the crossroads of cancer diagnosis, disease prognosis, and development of efficient cancer therapeutics;Advances in Cancer Biology - Metastasis;2022-07

4. p28GANK overexpression is associated with chemotherapy resistance and poor prognosis in ovarian cancer;Oncology Letters;2019-11-13

5. Gankyrin drives metabolic reprogramming to promote tumorigenesis, metastasis and drug resistance through activating β-catenin/c-Myc signaling in human hepatocellular carcinoma;Cancer Letters;2019-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3